Psoriasis, Arthropathic Psoriasis, IL23 Inhibitors, IL12/23 Inhibitors, Biologic Agents, Safety Profile, Retrospective Cohort Study
rheumatoid arthritis, sodium-glucose cotransporter-2 inhibitors, sulfonylureas, dipeptidyl peptidase-4 inhibitors, pioglitazone